TAK

TAK Operating Cash Flow (Statement)

¥953.63BTTM · JPY

Period ending:

TAK FY Cash from OperationsJPY
TAK FY Cash from Operations2000-03-31: ¥158.96B2001-03-31: ¥212.66B2002-03-31: ¥240.59B2003-03-31: ¥263.45B2004-03-31: ¥311.12B2005-03-31: ¥295.54B2006-03-31: ¥373.58B2007-03-31: ¥209.28B2008-03-31: ¥292.50B2009-03-31: ¥326.27B2010-03-31: ¥381.17B2011-03-31: ¥326.94B2012-03-31: ¥336.57B2013-03-31: ¥332.58B2014-03-31: ¥148.72B2015-03-31: ¥182.52B2016-03-31: ¥25.49B2017-03-31: ¥261.36B2018-03-31: ¥377.85B2019-03-31: ¥328.48B2020-03-31: ¥669.75B2021-03-31: ¥1.01T2022-03-31: ¥1.12T2023-03-31: ¥977.16B2024-03-31: ¥716.34B2025-03-31: ¥1.06T2026-03-31: ¥1.04T¥1.12T¥0.00
2000-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in JPY. Dates are period ends; a fiscal year may differ from a calendar year.

TAK operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 27 observations from Mar 31, 2000 to Mar 31, 2026.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Operating Cash Flow (Statement) — Annual fiscal periods (JPY)
Period endingOperating Cash Flow (Statement) (JPY)
1,041,431,000,000
1,057,182,000,000
716,344,000,000
977,156,000,000
1,123,105,000,000
1,010,931,000,000
669,752,000,000
328,479,000,000
377,854,000,000
261,363,000,000
25,491,000,000
182,517,000,000
148,720,000,000
332,579,000,000
336,570,000,000
326,938,000,000
381,168,000,000
326,273,000,000
292,496,000,000
209,280,000,000
373,575,000,000
295,539,000,000
311,122,000,000
263,449,000,000
240,586,000,000
212,662,000,000
158,962,000,000

Compare operating cash flow (statement)

All TAK financial metrics · TAK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.